Maven, a women’s health clinic and benefits platform, has had no shortage of macroeconomic plot twists: from investors questioning its market size to the still on-going pandemic to, most recently, the startling overturn of Roe v. Wade. But CEO and founder Kate Ryder stays optimistic. “This is a massive industry that’s full of entrenched interests […]
Maven, now valued at $1.35 billion, is answering a country-wide demand: more fertility benefits by Natasha Mascarenhas originally published on TechCrunch...